Renalda Dashi
Family · Southfield, MINPI 1538892310
Payments from drug & device makers
Across 149 payments — averaging $40.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Cequr Corporation$963
- Novo Nordisk$379
- Mannkind Corporation$264
- Novartis$230
- Cordis US CORP.$225
- plus $2K from 33 others
What the payments were for
- Travel & lodging$1,32322%
- Food & beverage$4,61177%
- Education$431%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 21 | $1,996 |
| Cequr Corporation | 1 | $963 |
| Novo Nordisk | 14 | $379 |
| Mannkind Corporation | 12 | $264 |
| Novartis | 13 | $230 |
| Cordis US CORP. | 11 | $225 |
| Corcept Therapeutics | 9 | $196 |
| Bayer | 9 | $181 |
| Sequel Med Tech, LLC | 2 | $168 |
| BETA Bionics, Inc. | 2 | $155 |
| Terumo Medical Corporation | 4 | $110 |
| Abbott | 2 | $106 |
| Madrigal Pharmaceuticals | 3 | $103 |
| Lilly USA, LLC | 6 | $94 |
| AbbVie | 3 | $71 |
| Amgen | 4 | $67 |
| Boehringer Ingelheim | 3 | $53 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Dexcom, Inc. | 2 | $48 |
| Radius Health, Inc. | 2 | $48 |
| Alvogen Inc | 2 | $42 |
| Ascensia Diabetes Care US Inc. | 2 | $41 |
| Amneal Pharmaceuticals LLC | 2 | $40 |
| Amphastar Pharmaceuticals, Inc. | 2 | $34 |
| Averitas Pharma Inc. | 1 | $30 |
| Neurocrine Biosciences, Inc. | 1 | $27 |
| Merck | 1 | $25 |
| Recordati_rare_diseases_inc. | 1 | $25 |
| Ascendis Pharma Endocrinology Inc | 1 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $24 |
| Boston Scientific | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Chiesi USA, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Bard Peripheral Vascular, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,976 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 59 | $58,173 |
| EntrestoSacubitril/Valsartan | 38 | $31,797 |
| FarxigaDapagliflozin Propanediol | 22 | $27,946 |
| XareltoRivaroxaban | 18 | $18,376 |
| JardianceEmpagliflozin | 24 | $15,643 |
| ClopidogrelClopidogrel Bisulfate | 237 | $2,220 |
| Potassium Chloride | 112 | $2,033 |
| Hydralazine Hcl | 35 | $1,632 |
| Atorvastatin Calcium | 173 | $1,552 |
| Carvedilol | 121 | $1,194 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 60 | $997 |
| Metoprolol Succinate | 60 | $910 |
| Nifedipine ErNifedipine | 13 | $832 |
| Amiodarone Hcl | 12 | $759 |
| Pravastatin Sodium | 48 | $507 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $230 | $31,79738 claims |
| AstraZenecaFarxiga | $14 | $27,94622 claims |
| Johnson & JohnsonXarelto | $14 | $18,37618 claims |
| Boehringer IngelheimJardiance | $53 | $15,64324 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Southfield
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
- Tracy RobertsonBay City$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.